
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
IQVIA announced the launch of IQVIA Biotech and its new approach to delivering clinical and commercial solutions for small biotech and biopharma companies. The suite delivers operating proceudres, specialized teams, and servies to life sciences in achieving drug development and commercialization goals. IQVIA Biotech works from initial planning to trial design and implementation to market launch and commercialization.
To read the full release, click






